| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |